MTHFR Gene Mutation and Autoimmune Disease: What's the Connection?

If you've had genetic testing done, or if a functional medicine provider has mentioned “methylation,” you may have come across the term MTHFR. It refers to a gene — methylenetetrahydrofolate reductase — that provides instructions for an enzyme involved in processing folate (vitamin B9) and regulating a process called methylation, which touches nearly every system in the body, including immune function.

MTHFR gene variants are extremely common; having one doesn't mean something is inherently wrong. What matters more is understanding what the gene does and whether your individual nutrient status and symptoms suggest it's worth addressing as part of your care.

MTHFR enters autoimmune conversations because folate metabolism touches methylation, homocysteine, and how some people feel on certain supplements. A gene variant is not the same thing as a diagnosis, and it is not a proven cause of autoimmune disease.

The MTHFR enzyme converts folate into its active, usable form (5-MTHF), which is required for methylation — a chemical process involved in DNA repair, neurotransmitter production, detoxification, and regulation of gene expression, including genes that influence immune cell behavior.

Common variants of the MTHFR gene (most notably C677T and A1298C) can reduce the enzyme's efficiency, which may lead to lower levels of active folate and, in some cases, elevated homocysteine — an amino acid linked to inflammation when chronically elevated.

Methylation influences how immune cells communicate and regulate inflammation, which is why some functional medicine providers consider MTHFR variants as one piece of the puzzle in people with autoimmune conditions — particularly when nutrient testing shows low active folate, low B12, or elevated homocysteine alongside ongoing symptoms.

It's important to be clear: having an MTHFR variant does not cause autoimmune disease on its own, and most people with an MTHFR variant never develop one. It's one of many factors that may be considered as part of a broader root-cause evaluation, not a diagnosis in itself.

Rather than testing for MTHFR in isolation, a thorough functional medicine evaluation typically looks at actual nutrient levels (active folate, B12, homocysteine), symptoms, and your broader health picture — since two people with the same gene variant can have very different nutrient statuses and needs.

When relevant, support may include dietary changes and targeted supplementation with active forms of folate and B12, always personalized to your labs rather than applied as a blanket recommendation.

MTHFR encodes an enzyme that helps process folate. Two variants, often called C677T and A1298C, are common in the general population. Carrying one copy, or even two copies of C677T, changes enzyme activity. It does not mean the gene is broken, and it does not mean you have a rare metabolic disease. MedlinePlus Genetics describes MTHFR-related illness as uncommon and separate from the everyday variants that direct-to-consumer tests report.

The Centers for Disease Control and Prevention has said that common MTHFR variants are not, by themselves, a reason for a special medical workup in most people, and that folic acid intake recommendations do not change because of them. The American College of Medical Genetics has advised against ordering MTHFR testing as a routine clinical test. Those statements are the counterweight to marketing that treats a variant as the root of fatigue, miscarriage, depression, and autoimmunity all at once.

Homocysteine can be higher when folate, B12, or B6 status is low, and the C677T variant can push homocysteine up modestly, especially if folate intake is poor. A homocysteine level is a blood test with a result you can act on. A genotype, without that context, mostly produces a label.

Researchers have looked for links between MTHFR variants and autoimmune or inflammatory conditions. Findings are inconsistent across studies and populations. A variant that is present in a large share of healthy people cannot, by itself, explain why one person has Hashimoto's or lupus. If it were decisive, those diseases would be far more common than they are among variant carriers.

What can be relevant in clinic is the nutrient side of the same pathway. Low folate or low B12 can cause fatigue, neuropathy, and anemia that patients sometimes fold into their autoimmune story. Those deficiencies are worth testing with standard labs when symptoms fit. Treating a measured deficiency is ordinary medicine. Treating a genotype with a stack of methylated supplements, without a deficiency, is not.

Some people feel worse on folic acid and better on a methylfolate product, or the reverse. That experience deserves a hearing. It is still an n-of-one observation, not proof that the variant caused an autoimmune disease. Change one supplement at a time, with the clinician who can see your labs, and stop if numbness, anxiety, or a rash shows up.

At Dr. Autoimmune an MTHFR result that a patient already has is read after the history, not before it. We ask what symptoms are actually present, what the thyroid, inflammatory, and blood-count labs show, and whether folate or B12 has ever been measured. If homocysteine is high, we look for the nutritional reason and for kidney function, medications, and hypothyroidism, all of which can raise it.

We do not order MTHFR genotyping as a first-line autoimmune test. If you already paid for it, bring the raw result so we can say plainly whether it changes anything. Most of the time the useful next step is a standard nutrient lab or a look at the autoimmune disease you already have, not another methylation panel.

Be cautious with doses of methylfolate and methylcobalamin sold as 'detox' or 'immune reset' products. High doses are not harmless for everyone. They can aggravate anxiety in some people, and they do not replace thyroid hormone, disease-modifying drugs, or a gluten-free diet in celiac disease.

Ask whether your folate and B12 have been measured, not just whether you 'have MTHFR.' Ask what symptom would be explained by a high homocysteine and what symptom would not. Ask which supplement dose is being proposed and what side effect should make you stop. If the answer is that every autoimmune disease starts with this gene, you are hearing a sales script, not a differential diagnosis.

Family members often share variants and do not share diseases. A relative's supplement plan is not your lab result. Retest nutrients if the diet, a pregnancy, or a medication such as metformin has changed the picture. Leave the genotype where it belongs: as background, not as the name of your illness.